Wellington Management Group LLP Atreca, Inc. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.87 - $6.29 $5.55 Million - $12.2 Million	-1,934,255 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $2.53 Million - $4.68 Million	-516,198 Reduced 21.07%	1,934,255 $12.1 Million
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $13.2 Million - $23.3 Million	-1,688,844 Reduced 40.8%	2,450,453 $20.9 Million
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $10.2 Million - $15.1 Million	781,313 Added 23.27%	4,139,297 $63.5 Million
Q4 2020 Feb 12, 2021	SELL	$13.03 - $17.09 $2.43 Million - $3.19 Million	-186,802 Reduced 5.27%	3,357,984 $54.2 Million
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $3 Million - $5.5 Million	237,080 Added 7.17%	3,544,786 $49.5 Million
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $154,271 - $288,950	12,322 Added 0.37%	3,307,706 $70.4 Million
Q1 2020 May 14, 2020	SELL	$11.4 - $27.28 $882,759 - $2.11 Million	-77,435 Reduced 2.3%	3,295,384 $54.5 Million
Q4 2019 Feb 11, 2020	BUY	$9.68 - $18.67 $32.6 Million - $63 Million	3,372,819 New	3,372,819 $52.2 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.